Abstract:BackgroundTakayasu’s arteritis (TAK) is an idiopathic systemic vasculitis characterized by the involvement of the aorta and its major branches [1]. The supra-aortic arteries are often involved in TAK, with the reported prevalence ranging from 40% to 84% [2-3]. Importantly, patients with supra-aortic involvement carry a higher risk of neurological severe ischemic events (SIE) [4-5]. The common carotid artery (CCA) is the most affected artery and is more closely associated with neurologic symptoms than other supra-aortic arteries [6]. Ultrasonography (US) has been regarded as the most popular, user-friendly, and repeatable tool for the diagnosis and follow-up of CCA injuries.ObjectivesOur aim was to characterize TAK with supra-aortic involvement and determine the associations between clinical features, carotid US parameters, and neurological SIE.MethodsPatients with supra-aortic involvement including brachiocephalic trunk, bilateral common carotid artery and internal carotid artery, and bilateral subclavian and vertebral artery and baseline carotid US examination were enrolled. Bilateral carotid diameter, intima-media thickness (IMT), and peak systolic velocity (PSV) were measured by US. Then, IMT/diameter ratio (IDR) was calculated. Risk factors associated with neurological SIE were analyzed by multivariate logistic regression.ResultsTotally, 295 patients were included, of whom 93 (31.5%) experienced neurological SIE, with common carotid artery involved (81.7%). Involved supra-aortic artery distribution (p=0.04) and number (p<0.01) differed between neurologic and non-neurologic SIE subjects, showing higher prevalence of common carotid and vertebral artery involvement in cases with neurological SIE and 57.1% neurological SIE patients having more than four involved arteries. The left carotid IMT (p=0.03) and IDR (p<0.01) differed between patients with and without neurological SIE. The left carotid IDR (cut-off value ≥0.55, odds ratio [OR] 4.46; 95% confidence interval [CI] 2.05-9.71; p<0.01) and PSV (≤76 cm/s, OR 3.38; 95% CI 1.62-7.04; p<0.01) and involved supra-aortic artery number (≥4, OR 3.16; 95% CI 1.54-6.47; p<0.01) were independently associated with neurological SIE.ConclusionThe left carotid IDR, PSV and involved supra-aortic artery number would perform as valuable markers for recognizing neurological SIE in TAK patients with supra-aortic lesions.References[1]Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med 1994; 120: 919-29.[2]Cong XL, Dai SM, Feng X, et al. Takayasu’s arteritis: clinical features and outcomes of 125 patients in China. Clin Rheumatol 2010; 29: 973-81.[3]Mirouse A, Biard L, Comarmond C, et al. Overall survival and mortality risk factors in Takayasu’s arteritis: a multicenter study of 318 patients. J Autoimmun 2019; 96: 35-9.[4]Porter A, Youngstein T, Tombetti E, Mason JC. Biologic therapy in supra-aortic Takayasu arteritis can improve symptoms of cerebral ischaemia without surgical intervention. Rheumatology (Oxford) 2020; 59 Suppl 3: iii28-32.[5]Michailidou D, Rosenblum JS, Rimland CA, Marko J, Ahlman MA, Grayson PC. Clinical symptoms and associated vascular imaging findings in Takayasu’s arteritis compared to giant cell arteritis. Ann Rheum Dis 2020; 79: 262-7.[6]Schäfer VS, Jin L, Schmidt WA. Imaging for diagnosis, monitoring, and outcome prediction of large vessel vasculitides. Curr Rheumatol Rep 2020; 22: 76.Disclosure of InterestsNone declared

[Chinese guideline for the diagnosis and treatment of Takayasu's arteritis(2023)]

[Recommendations of diagnosis and treatment of Takayasu's arteritis in China]

Management of Cerebral Ischemia Due to Takayasu's Arteritis.

Pan American League of Associations for Rheumatology Guidelines for the Treatment of Takayasu Arteritis

Updates in the diagnosis and management of Takayasu's arteritis

A retrospective study of infantile-onset Takayasu arteritis: experience from a tertiary referral center in China

Current Immunosuppressive Treatment for Takayasu Arteritis

Chinese expert investigation on diagnosis and disease activity evaluation in Takayasu's arteritis

Evaluation of clinical measurements and development of new diagnostic criteria for Takayasu arteritis in a Chinese population.

Epidemiology of Takayasu Arteritis in Shanghai: A Hospital‐based Study and Systematic Review

[Fundus manifestation and treatment of Takayasu's arteritis]

[The clinical characteristics of Takayasu's arteritis with glomerulonephropathy]

Coronary artery calcification in Takayasu's arteritis: clinical characteristics and risk factors

A COMPREHENSIVE PROFILE OF CHEMOKINES IN THE PERIPHERAL BLOOD AND VASCULAR TISSUE OF PATIENTS WITH TAKAYASU ARTERITIS

Carotid intima-media thickness/diameter ratio and peak systolic velocity as risk factors for neurological severe ischemic events in takayasu's arteritis

Clinical Analysis of 112 Patients with Takayasu's Arteritis

Aneurysms in Takayasu's Arteritis: a Retrospective Study of Chinese Patients

An increased major vessel uptake by 18F-FDG-PET/CT in NIH criteria inactive patients with Takayasu's arteritis.

Study on clinical characteristics and therapeutic outcomes of 173 patients with Takayasu arteritis

The Critical Role of IL-6 in the Pathogenesis of Takayasu Arteritis.

Clinical Characteristics, Interdisciplinary Treatment and Follow-Up of 14 Children with Takayasu Arteritis